The article names visible cloudiness, crystallization, or color change as indications that medication may have been exposed to improper temperatures, and says medication in that condition should not be used
& Vitetta, L
What the weight-loss drugs may mean for women's treatment
To determine which kinase was involved in phosphorylation of GSTP at Ser184 in LPS-stimulated macrophages, we treated RAW264.7 cells with PKA or PKC inhibitor, respectively
Retatrutide, which activates GLP-1, GIP, and glucagon receptors is in late clinical development
Seventh, we performed a sensitivity analysis excluding individuals treated with systemic glucocorticoids within the last year prior to inclusion, while not allowing follow-up to continue past initiation of systemic glucocorticoid treatment